ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre

The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of Virology (NIV) and other research institutes are set to launch phase-3 clinical trials of the recombinant dengue vaccine, said Apurva Chandra, Union ...

Related Keywords

India ,New Delhi ,Delhi ,China ,Russia ,Geneva ,Genè ,Switzerland ,South Africa ,Brazil ,Apurva Chandra ,Vaccine Research ,Indian Council Of Medical Research ,Africa Health ,World Health Organization ,Development Centre ,Union Health ,National Institute Of Virology ,World Health Assembly ,Indian Council ,Medical Research ,Pune Based National Institute ,Union Health Secretary ,Health Minister Meeting ,Health Secretary ,Kyasanur Forest Disease ,Human Papillomavirus ,Mycobacterium Tuberculosis Vaccine ,Action Plan ,Antimicrobial Resistance ,